{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:28:30Z","timestamp":1770352110280,"version":"3.49.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T00:00:00Z","timestamp":1266364800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0009276","type":"journal-article","created":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T23:09:05Z","timestamp":1266361745000},"page":"e9276","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Novel HIV-1 Knockdown Targets Identified by an Enriched Kinases\/Phosphatases shRNA Library Using a Long-Term Iterative Screen in Jurkat T-Cells"],"prefix":"10.1371","volume":"5","author":[{"given":"Sylvie","family":"Rato","sequence":"first","affiliation":[]},{"given":"Sara","family":"Maia","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Brito","sequence":"additional","affiliation":[]},{"given":"Leonor","family":"Resende","sequence":"additional","affiliation":[]},{"given":"Carina F.","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Moita","sequence":"additional","affiliation":[]},{"given":"Rui P.","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Moniz-Pereira","sequence":"additional","affiliation":[]},{"given":"Nir","family":"Hacohen","sequence":"additional","affiliation":[]},{"given":"Luis Ferreira","family":"Moita","sequence":"additional","affiliation":[]},{"given":"Joao","family":"Goncalves","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2010,2,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/453289a","article-title":"25 years of HIV.","volume":"453","author":"AS Fauci","year":"2008","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nrd2336","article-title":"HIV drug development: the next 25 years.","volume":"6","author":"C Flexner","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/scientificamerican1108-78","article-title":"Can HIV be cured?","volume":"299","author":"M Stevenson","year":"2008","journal-title":"Sci Am"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV drug resistance.","volume":"350","author":"F Clavel","year":"2004","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm0702-673","article-title":"Charting HIV&apos;s remarkable voyage through the cell: Basic science as a passport to future therapy.","volume":"8","author":"WC Greene","year":"2002","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrmicro1541","article-title":"Host factors exploited by retroviruses.","volume":"5","author":"SP Goff","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1152725","article-title":"Identification of host proteins required for HIV infection through a functional genomic screen.","volume":"319","author":"AL Brass","year":"2008","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2008.07.032","article-title":"Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.","volume":"135","author":"R Konig","year":"2008","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.chom.2008.10.004","article-title":"Genome-scale RNAi screen for host factors required for HIV replication.","volume":"4","author":"H Zhou","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"19463","DOI":"10.1074\/jbc.M109.010033","article-title":"A Genome-wide Short Hairpin RNA Screening of Jurkat T-cells for Human Proteins Contributing to Productive HIV-1 Replication.","volume":"284","author":"ML Yeung","year":"2009","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","article-title":"Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.","volume":"80","author":"T Hunter","year":"1995","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome.","volume":"1","author":"AL Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S1359-6446(05)03666-4","article-title":"The druggable genome: an update.","volume":"10","author":"AP Russ","year":"2005","journal-title":"Drug Discov Today"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","article-title":"Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.","volume":"74","author":"U O'Doherty","year":"2000","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nbt1049","article-title":"Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters.","volume":"23","author":"M Amendola","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.1067081","article-title":"Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors.","volume":"295","author":"C Lois","year":"2002","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/JVI.72.6.4694-4703.1998","article-title":"CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization.","volume":"72","author":"N Sullivan","year":"1998","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1128\/JVI.74.18.8524-8531.2000","article-title":"Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug.","volume":"74","author":"F Mammano","year":"2000","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2008.10.007","article-title":"Knockdown screens to knockout HIV-1.","volume":"135","author":"SP Goff","year":"2008","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-4690-6-78","article-title":"siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication.","volume":"6","author":"KH Kok","year":"2009","journal-title":"Retrovirology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4690-5-11","article-title":"Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy.","volume":"5","author":"P Chugh","year":"2008","journal-title":"Retrovirology"},{"key":"ref22","first-page":"3","article-title":"Regulation of HIV-1 transcription by protein phosphatase 1.","volume":"5","author":"S Nekhai","year":"2007","journal-title":"Curr HIV Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-4690-5-15","article-title":"Hitting HIV where it hides.","volume":"5","author":"AI Dayton","year":"2008","journal-title":"Retrovirology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"D417","DOI":"10.1093\/nar\/gkn708","article-title":"Human immunodeficiency virus type 1, human protein interaction database at NCBI.","volume":"37","author":"W Fu","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1000437","DOI":"10.1371\/journal.ppat.1000437","article-title":"Host cell factors in HIV replication: meta-analysis of genome-wide studies.","volume":"5","author":"FD Bushman","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.str.2007.08.007","article-title":"Structural basis of EZH2 recognition by EED.","volume":"15","author":"Z Han","year":"2007","journal-title":"Structure"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1074\/jbc.274.3.1635","article-title":"HEED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1.","volume":"274","author":"R Peytavi","year":"1999","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"12507","DOI":"10.1128\/JVI.77.23.12507-12522.2003","article-title":"The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1.","volume":"77","author":"S Violot","year":"2003","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1097-2765(04)00004-8","article-title":"HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane.","volume":"13","author":"V Witte","year":"2004","journal-title":"Mol Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-4690-4-37","article-title":"Human Polycomb group EED protein negatively affects HIV-1 assembly and release.","volume":"4","author":"D Rakotobe","year":"2007","journal-title":"Retrovirology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.virol.2004.10.023","article-title":"HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases.","volume":"331","author":"E Devroe","year":"2005","journal-title":"Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-5793(03)00474-5","article-title":"NDR family of AGC kinases\u2013essential regulators of the cell cycle and morphogenesis.","volume":"546","author":"R Tamaskovic","year":"2003","journal-title":"FEBS Lett"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.physiol.68.040104.131654","article-title":"Sgk kinases and their role in epithelial transport.","volume":"68","author":"J Loffing","year":"2006","journal-title":"Annu Rev Physiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/sj.cdd.4401583","article-title":"Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism.","volume":"12","author":"K Muthumani","year":"2005","journal-title":"Cell Death Differ"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.antiviral.2006.06.008","article-title":"Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).","volume":"72","author":"EA Schafer","year":"2006","journal-title":"Antiviral Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1471-4159.2006.03698.x","article-title":"Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.","volume":"97","author":"B Hui","year":"2006","journal-title":"J Neurochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/529525","article-title":"Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.","volume":"197","author":"SK Choudhary","year":"2008","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tox.2003.06.001","article-title":"Nucleotide excision repair and its interplay with transcription.","volume":"193","author":"A van Hoffen","year":"2003","journal-title":"Toxicology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"9732","DOI":"10.1128\/JVI.71.12.9732-9742.1997","article-title":"Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair.","volume":"71","author":"ES Withers-Ward","year":"1997","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/viro.1998.9138","article-title":"HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr.","volume":"245","author":"A Gragerov","year":"1998","journal-title":"Virology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1182\/blood-2003-05-1635","article-title":"HIV-1 preferentially binds receptors copatched with cell-surface elastase.","volume":"102","author":"CL Bristow","year":"2003","journal-title":"Blood"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/emboj\/17.9.2607","article-title":"Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase.","volume":"17","author":"JM Jacque","year":"1998","journal-title":"Embo J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/00002030-199909100-00006","article-title":"Extracellular HIV-1 Tat protein differentially activates the JNK and ERK\/MAPK pathways in CD4 T cells.","volume":"13","author":"C Mischiati","year":"1999","journal-title":"Aids"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"27981","DOI":"10.1074\/jbc.274.39.27981","article-title":"ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB.","volume":"274","author":"X Yang","year":"1999","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2000.0581","article-title":"Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry.","volume":"276","author":"W Popik","year":"2000","journal-title":"Virology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02970151","article-title":"HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.","volume":"28","author":"AL Greenway","year":"2003","journal-title":"J Biosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1074\/jbc.M608307200","article-title":"Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells: involvement of antiapoptotic BCL2 and c-IAP1 genes.","volume":"282","author":"S Mishra","year":"2007","journal-title":"J Biol Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0009276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:36:18Z","timestamp":1590626178000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0009276"}},"subtitle":[],"editor":[{"given":"Olivier","family":"Schwartz","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2010,2,17]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,2,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0009276","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,17]]}}}